VERSANT VENTURE CAPITAL VI, L.P. sold 21.9% of their position (350K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.15M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/12/2025ACC: 0000950170-25-085490
10% Owner
Since Jun 2021
-350K
Net shares
Net seller
$10.15M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
350K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−350K
Price / share
$29.00
Trade value
$10.15M
% of position
21.9%
6/10/2025
1.60M→1.25M
Total
Net shares
−350K
Net value
-$10.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/10/2025 | S · Sale | −350K | $29.00 | $10.15M | 21.9% | 1.60M | 1.25M |
| Total | −350K | -$10.15M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned2.10M
Common Stock
IndirectShares owned842.16K
Total
2.10M direct·842.16K indirect2.94M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.10M | Direct |
| Common Stock | 842.16K | Indirect |
| Total | 2.94M | 2.10M direct·842.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported